Seymur Gahramanov

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.

Daniel Guillaume, Nancy D. Doolittle, Seymur Gahramanov et al. · PubMed · 2010 · 420 citations · Full text

Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival

Seymur Gahramanov, Leslie L. Muldoon, Csanád Várallyay et al. · Radiology · 2012 · 157 citations · Full text

Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study

Seymur Gahramanov, Ahmed M. Raslan, Leslie L. Muldoon et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 148 citations · Full text

Engineering, Health Sciences, Medical Imaging +8

Macrophage Imaging Within Human Cerebral Aneurysms Wall Using Ferumoxytol-Enhanced MRI: A Pilot Study

David Hasan, Kelly B. Mahaney, Vincent A. Magnotta et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 113 citations · Full text

Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question

Morad Nasseri, Seymur Gahramanov, João Prola Netto et al. · Neuro-Oncology · 2014 · 101 citations · Full text